Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexa S Green

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2010
Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemiaNicolas Chapuis, Jerome Tamburini, Alexa S Green, et al.
Blood|July 30, 2010
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translationAlexa S Green, Nicolas Chapuis, Thiago Trovati Maciel, et al.
Haematologica|September 22, 2011
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) studyFrançois Vergez, Alexa S Green, Jerome Tamburini, et al.
Blood|September 10, 2013
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemiaLise Willems, Nathalie Jacque, Arnaud Jacquel, et al.
Cell Reports|May 26, 2015
Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid LeukemiaPierre Sujobert, Laury Poulain, Etienne Paubelle, et al.
Science Advances|November 25, 2015
Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemiaAlexa S Green, Thiago T Maciel, Marie-Anne Hospital, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2010
Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemiaNicolas Chapuis, Jerome Tamburini, Alexa S Green, et al.
Blood|July 30, 2010
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translationAlexa S Green, Nicolas Chapuis, Thiago Trovati Maciel, et al.
Haematologica|September 22, 2011
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) studyFrançois Vergez, Alexa S Green, Jerome Tamburini, et al.
Blood|September 10, 2013
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemiaLise Willems, Nathalie Jacque, Arnaud Jacquel, et al.
Cell Reports|May 26, 2015
Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid LeukemiaPierre Sujobert, Laury Poulain, Etienne Paubelle, et al.
Science Advances|November 25, 2015
Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemiaAlexa S Green, Thiago T Maciel, Marie-Anne Hospital, et al.
Pageof 2